Funding for this research was provided by:
National Human Genome Research Institute (RM1HG008525)
Burroughs Wellcome Fund
Text and Data Mining valid from 2018-04-19
Received: 17 October 2017
Accepted: 5 April 2018
First Online: 19 April 2018
Ethics approval and consent to participate
: The protocols for recruitment of PGP participants for sequencing and creation of cell lines were approved by Harvard University’s Human Research Protection Program (IRB 15461). The pooling of these cell lines and estimation of individual donor proportion was also determined to not be human subjects research (IRB18–0480). All PGP participants consented for the sequencing of their own genetic material as well as the creation of their cell lines [CitationRef removed].
: GMC holds leadership positions in many companies related to DNA sequencing technologies. A full list of these companies is available atExternalRef removed. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.